The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of sarcopenia diagnosis defined by low muscle mass measured by bioelectrical impedance analysis (BIA) or computed tomography (CT) in combination with low muscle strength in older adults with cancer.
 
Tomohiro Nishijima
Consulting or Advisory Role - Hisamitsu Pharmaceutical
 
Mototsugu Shimokawa
No Relationships to Disclose
 
Keita Okahara
No Relationships to Disclose
 
Mikio Saito
No Relationships to Disclose
 
Noriyoshi Izaki
No Relationships to Disclose
 
Takeo Honda
No Relationships to Disclose
 
Kohei Arimizu
No Relationships to Disclose
 
Kenji Shinozaki
No Relationships to Disclose
 
Taito Esaki
Honoraria - Chugai Pharma; Daiichi Sankyo; Hisamitsu Pharmaceutical; Lilly; MSD; Ono Pharmaceutical; Roche Diagnostics Solutions; Taiho Pharmaceutical; Zeria Pharmaceutical
Research Funding - ALX Oncology (Inst); Amgen (Inst); Asahi Kasei (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Jazz Pharmaceuticals (Inst); MSD (Inst); Nihonkayaku (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
 
Masaru Morita
No Relationships to Disclose